Psychiatry · Sellersville, PA
NPI
1508995853
Since 2007
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
807 Lawn Ave
Sellersville, PA, 18960
Phone (215) 257-6551
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.1M
4,179 prescriptions
Company payments, 2025
$313
From 8 companies
Medicare prescription drug claims, 2024
In 2024, the drug Alan D Sofranko prescribed most often to Medicare patients was Benztropine Mesylate, with 381 prescriptions and refills. In total Alan D Sofranko wrote 4,179 Medicare prescriptions that cost $1.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Benztropine Mesylate Generic | 381 | 381 | 33 | $2,713 |
| Bupropion Xl Bupropion Hcl | 225 | 225 | 18 | $2,824 |
| Quetiapine Fumarate Generic | 196 | 196 | 13 | $2,194 |
| Haloperidol Generic | 179 | 179 | 16 | $2,975 |
| Trazodone Hcl Generic | 172 | 172 | 21 | $1,215 |
| Clozapine Generic | 172 | 172 | Under 11 | $5,328 |
| Olanzapine Generic | 167 | 167 | 16 | $2,077 |
| Clonazepam Generic | 162 | 162 | 11 | $844 |
| Lorazepam Generic | 141 | 142 | 16 | $956 |
| Naltrexone Hcl Generic | 141 | 141 | 11 | $3,592 |
| Prazosin Hcl Generic | 135 | 135 | Under 11 | $1,172 |
| Gabapentin Generic | 131 | 131 | 19 | $1,268 |
| Chlorpromazine Hcl Generic | 116 | 116 | 12 | $8,344 |
| Risperidone Generic | 115 | 115 | 13 | $884 |
| Topiramate Generic | 104 | 104 | Under 11 | $493 |
Brand drugs: 260 claims; generic drugs: 3,919 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan D Sofranko $313 ($313 in general payments such as food, travel and fees) from 8 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $98.79.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $98.79 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $53.92 |
| Janssen Pharmaceuticals, Inc JNJ | 2 | $45.54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $30.5 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $30.48 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $19.7 |
| Braeburn Inc. | 1 | $18.25 |
| Lundbeck LLC | 1 | $16.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.